Both the selection of engineered hESCs and the derivation of iPSCs depend on the collection of individual stem cell colonies, which are then expanded to obtain homogenous cell lines. Figure 2 ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakura General Hospital (SKGH) to transfer technology ...